NCT02897765 A Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer Status COMPLETED Phase PHASE1
NCT02883790 Effects of Somnage® in the Management on Sleep and Mood in Cancer Patients Status TERMINATED Phase NA
NCT02872701 OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules Status COMPLETED Phase PHASE2
NCT02871115 Pilot Study of a Pharmacy Intervention for Older Adults With Cancer Status COMPLETED Phase NA
NCT02869789 An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers Status COMPLETED Phase PHASE4
NCT02869217 Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02867371 Evaluation of the Archimedes™ System for Transparenchymal Nodule Access 2 Status COMPLETED Phase NA
NCT02861209 Collaborative Network to Take Responsibility for Oral Anticancer Therapy Status UNKNOWN Phase NA
NCT02852629 Assessment of a Tool for Decision Making in Case of Worsening Condition of Cancer Patients Status COMPLETED Phase N/A
NCT02847728 Pattern of Use and Safety/Effectiveness of Nivolumab in Routine Oncology Practice Status COMPLETED Phase N/A
NCT02846103 Study of Anti-telomerase T CD4 Immunity in Metastatic Lung Cancer Status COMPLETED Phase NA
NCT02845089 Treatment Patterns, Outcomes and Resource Use Study for Advanced Stage Non-Small Cell Lung Cancer (Squamous and Non-squamous) in the Kingdom of Saudi Arabia and United Arab Emirates Status COMPLETED Phase N/A
NCT02844608 Feasibility of Quality of Life Assessment in Routine Clinical Oncology Practice at the University Hospital of Besancon Status UNKNOWN Phase NA
NCT02836834 Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of an Anti-PD-1 mAb for Patients With Advanced Solid Tumors Status UNKNOWN Phase PHASE1
NCT02827357 Responses to Chemotherapy of Patients With Non-small Cell Lung Cancer Harboring a Known Somatic Activating HER2 Mutation Status COMPLETED Phase N/A